General Purpose
Active
ID: 1272633
·
First filed: May 22, 2006
California Life Sciences Political Action Committee
View
Receipt Summary
| Source Type | Distribution | Amount | Percentage |
|---|---|---|---|
| Other | $2.26M | 94.1% | |
| Committee | $80.3K | 3.3% | |
| Individual | $62K | 2.6% | |
| Total | $2.41M | 100% |
Receipts
| Donor | Total Amount | % of Total | |
|---|---|---|---|
|
Astrazeneca
Other
|
1.2% | ||
|
Nuvasive, Inc.
Other
|
1.1% | ||
|
Exelixis, Inc.
Other
|
1.0% | ||
|
Horizon Therapeutics Usa, Inc.
Other
|
1.0% | ||
|
Boehringer - Ingelheim Pharmaceuticals, Inc.
Other
|
0.9% | ||
|
Biogen Idec
Other
|
0.9% | ||
|
Celgene Corporation
Other
|
0.9% | ||
|
Abbott Laboratories
Other
|
0.8% | ||
|
Dexcom
Other
|
0.7% | ||
|
Amylin Pharmaceuticals
Other
|
0.7% | ||
|
Horizon Pharma
Other
|
0.6% | ||
|
Horizon Pharma Plc
Other
|
0.6% | ||
|
Amyris, Inc.
Other
|
0.6% | ||
|
Takeda Pharmaceuticals
Other
|
0.6% | ||
|
Boston Scientific
Other
|
0.6% | ||
|
Bristol-Myers Squibb Company
Other
|
0.6% | ||
|
Align Technology, Inc.
Other
|
0.6% | ||
|
Natera, Inc.
Other
|
0.5% | ||
|
Gilead Sciences Inc
Other
|
0.5% | ||
|
Hologic+Genprobe
Other
|
0.5% | ||
|
Astellas Pharmaceuticals
Other
|
0.5% | ||
|
Abbvie Political Action Committee
Committee
|
0.5% | ||
|
Nathan Fletcher for State Senate 2024
Committee
|
0.4% | ||
|
Biogen, Inc.
Other
|
0.4% | ||
|
Science Corporation
Other
|
0.4% |